ADENOSINE-5'-DIPHOSPHATE
P73954 — Membrane-associated protein slr1513
ECOD Domain Annotations
ECOD domains from AlphaFold model interacting with ligand DB16833
| UniProt | DrugBank | PDB Ligand | Domain Label | ECOD ID | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|
| No predicted ECOD data found | ||||||||
ECOD domains from experimental PDB structures interacting with ligand DB16833
| UniProt | DrugBank | PDB ID | Ligand Acc. | Chain | Res No. | Exp. Domain | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|---|---|
| P73954 | DB16833 | 7r2z | ADP | A | 201 | e7r2zA1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r2z | ADP | A | 201 | e7r2zB1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r2z | ADP | B | 201 | e7r2zB1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r2z | ADP | B | 201 | e7r2zC1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r30 | ADP | B | 202 | e7r30B1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r30 | ADP | B | 202 | e7r30C1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r30 | ADP | C | 201 | e7r30A1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r30 | ADP | C | 201 | e7r30C1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | A | 201 | e7r32A1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | A | 201 | e7r32B1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | B | 201 | e7r32B1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | B | 201 | e7r32C1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | C | 201 | e7r32A1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |
| P73954 | DB16833 | 7r32 | ADP | C | 201 | e7r32C1 | Alpha-beta plaits | GlnB-like | GlnB-like | P-II |